Publications by authors named "Steven P Vickers"

Claim this Profile
T
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding.
Nina Dedic, Lien Wang, Eva Hajos-Korcsok, Jacob Hecksher-Sørensen, Urmas Roostalu, Steven P Vickers

Mol Metab· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity Mouse Model.
Christophe Fromont, Alessio Atzori, Divneet Kaur, Lubna Hashmi, Graziella Greco, Steven P Vickers

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.
Steven P Vickers, Simon Goddard, Richard J Brammer, Peter H Hutson, David J Heal

J Psychopharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model.
David J Heal, Simon Goddard, Richard J Brammer, Peter H Hutson, Steven P Vickers

J Psychopharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lisdexamfetamine in a rat model of binge-eating.
Steven P Vickers, David Hackett, Fraser Murray, Peter H Hutson, David J Heal

J Psychopharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet.
Steven P Vickers, Sharon C Cheetham, Katie R Headland, Keith Dickinson, Rolf Grempler

Diabetes Metab Syndr Obes· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats.
Robert B Jones, Steven P Vickers, Sharon C Cheetham, Katie R Headland, Michael Mark

Eur J Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the DPP-4 inhibitor, linagliptin, in diet-induced obese rats: a comparison in naive and exenatide-treated animals.
Steven P Vickers, Sharon C Cheetham, Gareth D Birmingham, Helen L Rowley, Katie R Headland

Clin Lab· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models to explore the effects of CNS drugs on food intake and energy expenditure.
Steven P Vickers, Peter G Clifton

Neuropharmacology· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of animal models to evaluate novel anti-obesity agents.
Steven P Vickers, Helen C Jackson, Sharon C Cheetham

Br J Pharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.
James V Gardiner, Attia Bataveljic, Neekhil A Patel, Gavin A Bewick, Debabrata Roy, Steven P Vickers

Diabetes· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour.
Zoë D Thornton-Jones, Guy A Kennett, Steven P Vickers, Peter G Clifton

Psychopharmacology (Berl)· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
Zoë D Thornton-Jones, Guy A Kennett, Karen R Benwell, Dean F Revell, Anil Misra, Steven P Vickers

Pharmacol Biochem Behav· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists.
David R Adams, Jonathan M Bentley, Karen R Benwell, Michael J Bickerdike, Corinna D Bodkin, Steven P Vickers

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.
Zoë D Thornton-Jones, Steven P Vickers, Peter G Clifton

Psychopharmacology (Berl)· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin receptor ligands and the treatment of obesity.
Steven P Vickers, Colin T Dourish

Curr Opin Investig Drugs· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis